|
2018 Journal Article Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosisPender, Michael P., Csurhes, Peter A., Smith, Corey, Douglas, Nanette L., Neller, Michelle A., Matthews, Katherine K., Beagley, Leone, Rehan, Sweera, Crooks, Pauline, Hopkins, Tracey J., Blum, Stefan, Green, Kerryn A., Ioannides, Zara A., Swayne, Andrew, Aftab, Blake T., Hooper, Kaye D., Burrows, Scott R., Thompson, Kate M., Coulthard, Alan and Khanna, Rajiv (2018). Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis. JCI Insight, 3 (22) e124714. doi: 10.1172/jci.insight.124714 |
|
2018 Journal Article PLP1 mutations in patients with multiple sclerosis: identification of a new mutation and potential pathogenicity of the mutationsCloake, Nancy, Yan, Jun, Aminian, Atefeh, Pender, Michael and Greer, Judith (2018). PLP1 mutations in patients with multiple sclerosis: identification of a new mutation and potential pathogenicity of the mutations. Journal of Clinical Medicine, 7 (10) 342, 342. doi: 10.3390/jcm7100342 |
|
2018 Journal Article Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosisYan, Jun, Winterford, Clay M., Catts, Vibeke S., Pat, Betty K., Pender, Michael P., McCombe, Pamela A. and Greer, Judith M. (2018). Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis. Journal of Neuroimmunology, 320, 111-116. doi: 10.1016/j.jneuroim.2018.04.002 |
|
2018 Journal Article Onset symptoms, tobacco smoking, and progressive-onset phenotype are associated with a delayed onset of multiple sclerosis, and marijuana use with an earlier onsetTao, Chunrong, Simpson, Steve, Taylor, Bruce V., Blizzard, Leigh, Lucas, Robyn M., Ponsonby, Anne-Louise, Broadley, Simon, van der Mei, Ingrid, AusLong/Ausimmune Investigators Group, Dear, Keith, Dwyer, Terry, Kilpatrick, Trevor, Williams, David, Lechner-Scott, Jeanette, Shaw, Cameron, Chapman, Caron, Coulthard, Alan, Pender, Michael P. and Valery, Patricia (2018). Onset symptoms, tobacco smoking, and progressive-onset phenotype are associated with a delayed onset of multiple sclerosis, and marijuana use with an earlier onset. Frontiers in Neurology, 9 (JUN) 418. doi: 10.3389/fneur.2018.00418 |
|
2018 Conference Publication Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivoBagert, Bridget, Greer, Judith, Savage, Hannah, Beasley, Shannon, Juba, Gracy and Pender, Michael (2018). Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo. AAN 70th Annual Meeting, Los Angeles, CA United States, 21-27 April 2018. Philadelphia, PA United States: Wolters Kluwer. doi: 10.1212/wnl.90.15_supplement.s52.001 |
|
2018 Journal Article Reported changes in dietary behavior following a first clinical diagnosis of central nervous system demyelinationRussell, Rebecca D., Lucas, Robyn M., Brennan, Vanessa, Sherriff, Jill L., Begley, Andrea, Black, Lucinda J., The Ausimmune Investigator Group, Chapman, Caron, Coulthard, Alan, Dear, Keith, Dwyer, Terry, Kilpatrick, Trevor, Lucas, Robyn, McMichael, Tony, Pender, Michael P., Ponsonby, Anne-Louise, Taylor, Bruce, Valery, Patricia, van der Mei, Ingrid and Williams, David (2018). Reported changes in dietary behavior following a first clinical diagnosis of central nervous system demyelination. Frontiers in Neurology, 9 (MAR) 161. doi: 10.3389/fneur.2018.00161 |
|
2018 Journal Article Sun exposure across the life course significantly modulates early multiple sclerosis clinical courseSimpson, Steve, Van Der Mei, Ingrid, Lucas, Robyn M., Ponsonby, Anne-Louise, Broadley, Simon, Blizzard, Leigh, Taylor, Bruce, Dear, Keith, Dwyer, Terry, Taylor, Bruce V., Kilpatrick, Trevor, Williams, David, Lechner-Scott, Jeanette, Shaw, Cameron, Chapman, Caron, Coulthard, Alan, Pender, Michael P. and Valery, Patricia (2018). Sun exposure across the life course significantly modulates early multiple sclerosis clinical course. Frontiers in Neurology, 9 (FEB) 16. doi: 10.3389/fneur.2018.00016 |
|
2018 Conference Publication Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivoBagert, Bridget, Greer, Judith, Savage, Hannah, Beasley, Shannon, Juba, Gracy and Pender, Michael (2018). Antibodies specific for myelin proteolipid protein can inhibit remyelination in vivo. 70th Annual Meeting of the American Academy of Neurology (AAN), Los Angeles, California, 21-27 April 2018. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2017 Journal Article Incidence and prevalence of NMOSD in Australia and New ZealandBukhari, Wajih, Prain, Kerri M., Waters, Patrick, Woodhall, Mark, O'Gorman, Cullen M., Clarke, Laura, Silvestrini, Roger A., Bundell, Christine S., Abernethy, David, Bhuta, Sandeep, Blum, Stefan, Boggild, Mike, Boundy, Karyn, Brew, Bruce J., Brown, Matthew, Brownlee, Wallace J., Butzkueven, Helmut, Carroll, William M., Chen, Celia, Coulthard, Alan, Dale, Russell C., Das, Chandi, Dear, Keith, Fabis-Pedrini, Marzena J., Fulcher, David, Gillis, David, Hawke, Simon, Heard, Robert, Henderson, Andrew P. D. ... Broadley, Simon A. (2017). Incidence and prevalence of NMOSD in Australia and New Zealand. Journal of Neurology Neurosurgery and Psychiatry, 88 (8), 632-638. doi: 10.1136/jnnp-2016-314839 |
|
2017 Journal Article Stressful life events and the risk of initial central nervous system demyelinationSaul, Alice, Ponsonby, Anne-Louise, Lucas, Robyn M., Taylor, Bruce V., Simpson, Steve, Jr., Valery, Patricia, Dwyer, Terence, Kilpatrick, Trevor J., Pender, Michael P. and van der Mei, Ingrid A. F. (2017). Stressful life events and the risk of initial central nervous system demyelination. Multiple Sclerosis Journal, 23 (7), 1000-1007. doi: 10.1177/1352458516667566 |
|
2017 Journal Article Reactivity to novel autoantigens in patients with coexisting central nervous system demyelinating disease and autoimmune thyroid diseaseGreer, Judith M., Broadley, Simon and Pender, Michael P. (2017). Reactivity to novel autoantigens in patients with coexisting central nervous system demyelinating disease and autoimmune thyroid disease. Frontiers in Immunology, 8 (514) 514, 514. doi: 10.3389/fimmu.2017.00514 |
|
2017 Journal Article Defective T-cell control of Epstein-Barr virus infection in multiple sclerosisPender, Michael P., Csurhes, Peter A., Burrows, Jacqueline M. and Burrows, Scott R. (2017). Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis. Clinical and Translational Immunology, 6 (1) e126, 1-17. doi: 10.1038/cti.2016.87 |
|
2017 Conference Publication Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trialPender, Michael, Csurhes, Peter, Smith, Corey, Douglas, Nanette, Neller, Michelle, Beagley, Leone, Rehan, Sweera, Hopkins, Tracey, Thompson, Kate, Blum, Stefan, Green, Kerryn, Ioannides, Zara, Coulthard, Alan, Hooper, Kaye, Burrows, Scott and Khanna, Rajiv (2017). Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial. 69th Annual Meeting of the American Academy of Neurology (AAN), Boston, Massachusetts, 22-28 April 2017. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2017 Conference Publication Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosisPender, M. P., Csurhes, P. A., Smith, C., Douglas, N. L., Neller, M. A., Beagley, L., Rehan, S., Hopkins, T. J., Thompson, K. M., Blum, S., Green, K. A., Ioannides, Z. A., Coulthard, A., Hooper, K. D., Burrows, S. R. and Khanna, R. (2017). Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, France, 25-28 October 2017. London, United Kingdom: Sage Publications. |
|
2016 Journal Article Population attributable fractions and joint effects of key risk factors for multiple sclerosisVan Der Mei, I. A. F., Lucas, R. M., Taylor, B. V., Valery, P. C., Dwyer, T., Kilpatrick, T. J., Pender, M. P., Williams, D., Chapman, C., Otahal, P. and Ponsonby, A. L. (2016). Population attributable fractions and joint effects of key risk factors for multiple sclerosis. Multiple Sclerosis, 22 (4), 461-469. doi: 10.1177/1352458515594040 |
|
2016 Conference Publication Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosisGreer, J. M., Muller, D. M., Beasley, S. J., Trifilieff, E. and Pender, M. P. (2016). Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosis. ICI 2016 International Congress of Immunology, Melbourne, Australia, 21–26 August 2016. Weinheim, Germany: Wiley. |
|
2015 Conference Publication Impaired T cell control of Epstein-Barr virus infection in multiple sclerosisPender, Michael, Csurhes, Peter and Burrows, Scott (2015). Impaired T cell control of Epstein-Barr virus infection in multiple sclerosis. MS Research Australia Progress in MS Research Conference, Melbourne, Australia, Oct 29-30, 2015. London, EC1Y 1SP United Kingdom: SAGE PUBLICATIONS LTD. doi: 10.1177/1352458515616527 |
|
2014 Journal Article Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapyPender, Michael P. and Burrows, Scott R. (2014). Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clinical and Translational Immunology, 3 (10) e27, e27. doi: 10.1038/cti.2014.25 |
|
2014 Journal Article Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophreniaJones, Amanda L., Mowry, Bryan J., McLean, Duncan E., Mantzioris, Basil X., Pender, Michael P. and Greer, Judith M. (2014). Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia. Journal of Neuroimmunology, 269 (1-2), 68-75. doi: 10.1016/j.jneuroim.2014.02.008 |
|
2014 Journal Article Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosisPender, Michael P., Csurhes, Peter A., Smith, Corey, Beagley, Leone, Hooper, Kaye D., Raj, Meenakshi, Coulthard, Alan, Burrows, Scott R. and Khanna, Rajiv (2014). Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis. Multiple Sclerosis Journal, 20 (11), 1541-1544. doi: 10.1177/1352458514521888 |
